Sir Mene Pangalos, of the Cambridge-based pharmaceutical giant AstraZeneca, suggested the company could help. But there was a potential hitch - Oxford insisted the vaccine should be affordable ...
The study is testing a COVID-19 vaccine being developed by AstraZeneca and University of Oxford researchers at various sites, including the United Kingdom, where the adverse event was reported.
The vaccine in question is AstraZeneca (AZ) and the University of Oxford’s two-dose adenovirus vaccine candidate. This approval occurs in the context of an escalating Covid-19 crisis in the UK ...
The Falkland Islands Government has received a batch of Oxford/AstraZeneca Covid-19 vaccines, supplied by the UK government. These 960 doses arrived on 12 August and are being rolled out as part ...
Results that may be inaccessible to you are currently showing.